Literature DB >> 31280262

Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Anne-Laure Barbotin1,2, Maëliss Peigné1,3, Samuel Andrew Malone1, Paolo Giacobini4.   

Abstract

Since its initial discovery in the 1940s, research into the physiological actions of anti-Müllerian hormone (AMH), from its eponymous role in male developmental biology to its routine clinical use in female reproductive health, has undergone a paradigm shifting change. With several exciting studies recently reporting hitherto unforeseen AMH actions at all levels in the hypogonadal-pituitary-gonadal axis, the importance of this hormone for both hypothalamic and pituitary reproductive control is finding increasing support and significance. In this review, we will briefly summarize what is known about the traditional roles and biology of AMH and how this could be integrated with new findings of AMH actions at the level of the hypothalamic-pituitary axis. We also synthesize the important findings from these new studies and discuss their potential impact and significance to our understanding of one of the most common reproductive disorders currently affecting women, polycystic ovary syndrome.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Anti-Müllerian hormone; Hypothalamic-pituitary function; Polycystic ovary syndrome

Mesh:

Substances:

Year:  2019        PMID: 31280262      PMCID: PMC6878735          DOI: 10.1159/000500689

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  120 in total

1.  Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat.

Authors:  A E Herbison; S X Simonian; P J Norris; P C Emson
Journal:  J Neuroendocrinol       Date:  1996-01       Impact factor: 3.627

2.  Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus.

Authors:  Philippe Ciofi; Maurice Garret; Olivier Lapirot; Pierrette Lafon; Anne Loyens; Vincent Prévot; Jon E Levine
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

3.  Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.

Authors:  Joana Peñarrubia; Francisco Fábregues; Dolors Manau; Montserrat Creus; Gemma Casals; Roser Casamitjana; Franciso Carmona; Juan A Vanrell; Juan Balasch
Journal:  Hum Reprod       Date:  2005-01-21       Impact factor: 6.918

4.  Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia.

Authors:  P Fénichel; R Rey; S Poggioli; M Donzeau; D Chevallier; G Pointis
Journal:  Hum Reprod       Date:  1999-08       Impact factor: 6.918

Review 5.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 6.  Anti-Müllerian hormone is a gonadal cytokine with two circulating forms and cryptic actions.

Authors:  Ian S McLennan; Michael W Pankhurst
Journal:  J Endocrinol       Date:  2015-07-10       Impact factor: 4.286

7.  Mullerian inhibiting substance acts as a motor neuron survival factor in vitro.

Authors:  Pei-Yu Wang; Kyoko Koishi; Andrew B McGeachie; Michael Kimber; David T Maclaughlin; Patricia K Donahoe; Ian S McLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

8.  Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior.

Authors:  Pei-Yu Wang; Anna Protheroe; Andrew N Clarkson; Floriane Imhoff; Kyoko Koishi; Ian S McLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  Marsupial anti-Mullerian hormone gene structure, regulatory elements, and expression.

Authors:  Andrew J Pask; Deanne J Whitworth; Chai-An Mao; Ke-Jun Wei; Natasha Sankovic; Jennifer A M Graves; Geoffrey Shaw; Marilyn B Renfree; Richard R Behringer
Journal:  Biol Reprod       Date:  2003-09-17       Impact factor: 4.285

10.  Early metabolic derangements in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Manuel Maliqueo; Ethel Codner; Bárbara Echiburú; Nicolás Crisosto; Virginia Pérez; Francisco Pérez-Bravo; Fernando Cassorla
Journal:  J Clin Endocrinol Metab       Date:  2007-09-11       Impact factor: 5.958

View more
  15 in total

Review 1.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

2.  Anti-Müllerian hormone treatment enhances oocyte quality, embryonic development and live birth rate†.

Authors:  Niharika Sinha; Chad S Driscoll; Wenjie Qi; Binbin Huang; Sambit Roy; Jason G Knott; Jianrong Wang; Aritro Sen
Journal:  Biol Reprod       Date:  2022-09-12       Impact factor: 4.161

3.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

4.  Defining Reference Ranges for Serum Anti-Müllerian Hormone on a Large Cohort of Normozoospermic Adult Men Highlights New Potential Physiological Functions of AMH on FSH Secretion and Sperm Motility.

Authors:  Hamza Benderradji; Anne-Laure Barbotin; Maryse Leroy-Billiard; Julie Prasivoravong; François Marcelli; Christine Decanter; Geoffroy Robin; Valérie Mitchell; Jean-Marc Rigot; Antonino Bongiovanni; Florent Sauve; Luc Buée; Claude-Alain Maurage; Maryse Cartigny; Arnauld Villers; Vincent Prevot; Sophie Catteau-Jonard; Nicolas Sergeant; Paolo Giacobini; Pascal Pigny; Clara Leroy
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

5.  Gonadal Cycle-Dependent Expression of Genes Encoding Peptide-, Growth Factor-, and Orphan G-Protein-Coupled Receptors in Gonadotropin- Releasing Hormone Neurons of Mice.

Authors:  Csaba Vastagh; Veronika Csillag; Norbert Solymosi; Imre Farkas; Zsolt Liposits
Journal:  Front Mol Neurosci       Date:  2021-01-18       Impact factor: 5.639

6.  Anti-Müllerian Hormone, Growth Hormone, and Insulin-Like Growth Factor 1 Modulate the Migratory and Secretory Patterns of GnRH Neurons.

Authors:  Rossella Cannarella; Alyssa J J Paganoni; Stefania Cicolari; Roberto Oleari; Rosita A Condorelli; Sandro La Vignera; Anna Cariboni; Aldo E Calogero; Paolo Magni
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

Review 7.  Endometriosis and polycystic ovary syndrome are diametric disorders.

Authors:  Natalie L Dinsdale; Bernard J Crespi
Journal:  Evol Appl       Date:  2021-05-14       Impact factor: 4.929

Review 8.  Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence.

Authors:  Régine P M Steegers-Theunissen; Rosalieke E Wiegel; Pauline W Jansen; Joop S E Laven; Kevin D Sinclair
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

Review 9.  Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.

Authors:  Didier Dewailly; Anne-Laure Barbotin; Agathe Dumont; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-09       Impact factor: 5.555

10.  Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response.

Authors:  Kai-Lun Hu; Kwanghann Gan; Yue Ying; Junyan Zheng; Ruixue Chen; Jinglei Xue; Yiqing Wu; Yifeng Liu; Yimin Zhu; Lanfeng Xing; Dan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.